Despite treatment with Kalydeco (ivacaftor), females with cystic fibrosis (CF) continue to experience more lung exacerbations — periods…
Articles by Margarida Maia, PhD
Despite recent guidelines recommending nutrient consumption similar to the general population, many adults and late adolescents with cystic fibrosis…
Tezacaftor, a medication used to treat cystic fibrosis (CF), may unexpectedly trap certain fats…
Children with cystic fibrosis (CF) who are being treated with Symdeko (ivacaftor/tezacaftor) or Orkambi (ivacaftor/lumacaftor) experience few…
CFTR modulators may help control glucose (sugar) levels in the blood of people with cystic fibrosis (CF), according to…
Low doses of ETD001, an inhaled medication being develop by Enterprise Therapeutics to treat cystic fibrosis (CF),…
ARCT-032, a messenger RNA inhalation treatment being developed by Arcturus Therapeutics to restore a working protein in the…
Women with cystic fibrosis (CF) who have been pregnant three or more times are more likely to experience a…
Certain neutrophils, a type of immune cell that’s released quickly into the bloodstream to help fight off infections, appear to…
One year of treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor), branded Trikafta in the U.S., helped people with cystic fibrosis (CF)…